Genmab A/S (GMAB) M&A Name September 29, 2025 7:00 AM EDT
Firm Individuals
Jan van de Winkel – Co-Founder, President & CEO
Tahamtan Ahmadi – Govt VP, Chief Medical Officer & Head of Experimental Medicines
Anthony Pagano – Govt VP & CFO
Judith Klimovsky – Govt VP & Chief Growth Officer
Convention Name Individuals
Jonathan Chang – Leerink Companions LLC, Analysis Division
Michael Schmidt – Guggenheim Securities, LLC, Analysis Division
Asthika Goonewardene – Truist Securities, Inc., Analysis Division
Judah Frommer – Morgan Stanley, Analysis Division
Matthew Phipps – William Blair & Firm L.L.C., Analysis Division
Qize Ding – Rothschild & Co Redburn, Analysis Division
Rajan Sharma – Goldman Sachs Group, Inc., Analysis Division
Sebastiaan van der Schoot
Presentation
Operator
Whats up to Genmab’s convention name relating to its proposed acquisition of Merus. As a reminder, this convention name is being recorded. Throughout this phone convention, it’s possible you’ll be introduced with forward-looking statements that embody phrases akin to believes, anticipates, plans or expects. Precise outcomes might differ materially, for instance, on account of delayed or unsuccessful growth initiatives.
Genmab shouldn’t be underneath any obligation to replace statements relating to the long run, nor to substantiate such statements in relation to precise outcomes, until that is required by legislation. Please additionally observe that Genmab might maintain your private knowledge as indicated by you as a part of our Investor Relations outreach actions, to be able to replace you on Genmab going ahead. Please check with our web site for extra info on Genmab and our privateness coverage. I’d now like at hand the convention over to your first speaker as we speak, Jan van de Winkel. Please go forward.
Jan van de Winkel
Co-Founder, President & CEO
Whats up, and thanks for becoming a member of us. At the moment, we’re sharing a transformative step for Genmab, our deliberate acquisition of Merus. With me as we speak to current this thrilling information is our Chief Medical Officer, Tahi Ahmadi, who
